[Late extrapyramidal hyperkinesia during long-term administration of mebhydrolin].
D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003510:Cyclohexanes / Q000627:therapeutic use; D003679:Deglutition; D005021:Ethylamines / Q000627:therapeutic use; D005152:Facial Muscles / Q000503:physiopathology; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced* / Q000188:drug therapy; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008410:Masticatory Muscles / Q000503:physiopathology; D008875:Middle Aged; D010640:Phenothiazines / Q000627:therapeutic use; D014581:Urticaria / Q000188:drug therapy
D003510:Cyclohexanes; D005021:Ethylamines; D006634:Histamine H1 Antagonists; D007211:Indoles; D010640:Phenothiazines
Späte extrapyramidale Hyperkinesen während langzeitiger Einnahme von Mebhydrolin.